Diagnosis of Skin Cancer: From the Researcher Bench to the Patient Bedside, 2nd Edition

Dear Colleagues,

We are pleased to invite you to contribute original articles, communications, and review papers to be published in our Special Issue entitled “Diagnosis of Skin Cancer: From the Researcher Bench to the Patient Bedside” in the Journal of Clinical Medicine, which is now open for submissions.

The overall incidence and prevalence of skin cancer have shown a significant increase worldwide in recent decades. While melanoma accounts for about 80% of all skin-cancer-related deaths, non-melanoma skin cancers are the most common malignancies in fair-skinned populations.

We invite you to visit our website to access the first volume of our Special Issue, which is available at the following link:

https://www.mdpi.com/journal/jcm/special_issues/Skin_Cancer_Researcher_Bench_Patient_Bedside

This Special Issue will focus on the latest updates in diagnostic approaches for skin cancer, including various biomarkers, diagnostic devices, and imaging techniques (dermoscopy, optical coherence tomography, high-frequency ultrasound, reflectance confocal microscopy, etc.). New concepts on early detection, genomic and molecular testing, approaches guiding initial treatment decisions, and the monitoring of skin cancer therapy are also within the scope. The use of artificial intelligence to enhance the diagnostic capabilities of the previously mentioned imaging techniques and devices is also welcomed. Teledermatology, alone or in combination with artificial intelligence, is also a rapidly developing technology that has a key role in the early diagnosis of skin cancer; therefore, it is also included.

Basic, translational, and clinical research are equally welcome to this Special Issue.

Prof. Dr. Péter Holló
Dr. Zsuzsanna Lengyel
Dr. András Bánvölgyi
Dr. Norbert Kiss
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• dermatology
• skin cancer
• diagnosis
• melanoma
• imaging
• artificial intelligence
• dermoscopy

• Diagnosis of Skin Cancer: From the Researcher Bench to the Patient Bedside in Journal of Clinical Medicine (13 articles)